Omaveloxolone Capsules, 160 mg ( DrugBank: Omaveloxolone )

1 disease

ID	Disease name (Link within this page)	Number of trials
18	Spinocerebellar degeneration	1

18. Spinocerebellar degeneration

Clinical trials : 76 / Drugs : 98 - (DrugBank : 31) / Drug target genes : 44 - Drug target pathways : 65

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02255435 (ClinicalTrials.gov)	January 2015	30/9/2014	RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe	A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedre ...	Friedreich Ataxia	Drug: Omaveloxolone Capsules, 2.5 mg;Drug: Omaveloxolone Capsules, 5 mg;Drug: Omaveloxolone Capsules ...	Reata Pharmaceuticals, Inc.	AbbVie;Friedreich's Ataxia Research Alliance	Active, not recruiting	16 Years	40 Years	All	172	Phase 2	United States;Australia;Austria;Italy;United Kingdom;Brazil

First Previous1Next Last